Professional Documents
Culture Documents
Dematos2018 Gelatine
Dematos2018 Gelatine
PII: S2213-3437(18)30123-4
DOI: https://doi.org/10.1016/j.jece.2018.03.002
Reference: JECE 2243
To appear in:
Please cite this article as: Eric F.de Matos, Bianca S.Scopel, Aline Dettmer,
Citronella essential oil microencapsulation by complex coacervation with
leather waste gelatin and sodium alginate, Journal of Environmental Chemical
Engineering https://doi.org/10.1016/j.jece.2018.03.002
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
<AT>Citronella essential oil microencapsulation by complex coacervation with leather
waste gelatin and sodium alginate
PT
Vargas Street, Caxias do Sul, Brazil, ZIP CODE: 95070-560.
<AFF>bPost-Graduation Program in Mining, Metallurgical and Materials Engineering –
Federal University of Rio Grande do Sul – 9500, Bento Gonçalves Avenue, Porto Alegre,
RI
Brazil, ZIP CODE: 91501-970
<AFF>cChemical Engineering – University of Passo Fundo – BR 285, São José, Passo
SC
Fundo, Brazil, ZIP CODE: 99052-900
<PA>*
Correspondent authors: Bianca S. Scopel – Aline Dettmer.
ABSTRACT – Thousands of tons of chromium tanned leather wastes (CTLW) are
produced worldwide. Alternatives for their use as raw material in other processes are
U
particularly desired. In this study, gelatin extracted from CTLW was used in combination
with sodium alginate as encapsulating agent to prepare microcapsules of citronella essential
N
oil (CEO) by complex coacervation. The effect of gelatin and CEO concentration on the
encapsulation efficiency was investigated using commercial gelatin. Best encapsulation
A
conditions (mainly determined by morphology parameters) were found when 4% of gelatin
and 10% of CEO were used, resulting in 83.5% of microencapsulation yield.
M
Microencapsulation with CTLW gelatin was performed according to the best encapsulation
conditions. It resulted in an efficiency of 73.7%, produced microcapsules with a diameter of
434.06 µm, and with a core completely covered by the encapsulating agent.
D
Microencapsulation process with gelatin from CTLW, as presented in this paper, was
shown to be an effective method that will allow controlled release of CEO.
TE
<H1>1. INTRODUCTION
Chromium tanned leather wastes (CTLW) are generated after hides are tanned with
chromium III, when the leather is shaved to even out its thickness. This process generates,
CC
more specifically, wet blue leather wastes, which have not being through finishing
processes, as dyeing. Leather waste is made of a fibrous structural protein, called collagen,
which is crosslinked with chromium III. Chromium content in CTLW ranges from 3 to 6%
A
[1]. Alternatives targeting CTLW reuse involve from chromium to gelatin recovery.
Chromium can be used in the tanning process and gelatin is applied as raw material to
produce high added value products such as polymeric films or microcapsules [2-5].
Microencapsulation is a technology that applies thin polymeric coatings on solids, liquid
droplets, or gaseous materials in order to form particles called microcapsules. These
particles can release their content under specific conditions at a specific speed [6,7].
Complex coacervation is a process used to produce microcapsules. It forms a coating
capable of protecting the encapsulated active compounds [8,9]. This process consists of a
spontaneous phase separation, which leads to the formation of an insoluble polymer
complex (coacervate – the polymer-rich phase), and of another phase, which is poor in
polymer [10]. Complex coacervation involves at least two substances, typically
biopolymers of opposite ionic charges, in an aqueous system. The basic principle for the
formation of ionic charges on biopolymers, usually a protein and a polysaccharide, is the
pH change [11]. Proteins are positively charged below their isoelectric point and negatively
charged above it. Polysaccharides with anionic carboxyl groups, in their turn, act as
polyanions and, in contact with proteins, produce electrostatic complexes at pH values
PT
ranging generally from 2 to 5, depending on the type of protein [12,13]. Due to these
characteristics, gelatin and sodium alginate are appropriate coating materials for
microencapsulation processes [14].
Essential oils are volatile substances made of a complex mixture of components found in
RI
herbs. These components are terpenes, sesquiterpenes, and, in some plants,
phenylpropanoids, with small molecules such as alcohols, aldehydes and short-chain
SC
ketones. Oils have limited use due to their volatile characteristics, sensitivity to heat, and
easy oxidation. Thus, they require some external protection for appropriate use [15].
Citronella essential oil (CEO) has been widely used due to its medicinal and aromatic
properties. Its main components are citronellal, geraniol, and citronellol. Citronellol is
U
considered an excellent insect repellent, and presents bactericide and antifungal action [16].
The microencapsulation of volatile essential oils can be an effective solution to increase
N
their stability and, consequently, to improve their efficiency, giving them a longer lifetime.
The aim of this study was, therefore, to produce microcapsules containing CEO using
A
CTLW gelatin and sodium alginate by complex coacervation.
<H1>2. MATERIAL AND METHODS
M
<H2>2.1. Material
D
CTLW used in this work (wet blue shavings) were provided by a local tannery (Ritter –
Brazil). Gelatin was extracted from it with magnesium oxide (Neon, Brazil). Sodium
TE
alginate (Dinâmica, Brazil), glutaraldehyde (Dinâmica, Brazil), and acetic acid (Vetec,
Brazil) were used in the microencapsulation process of CEO (Cimbopogon winterianus).
For microencapsulation, it was also used a commercial gelatin (Dr. Oetker, Brazil) and the
EP
For alkaline hydrolysis, 50 g of CTLW were mixed with 2 g of MgO and 250 mL of
deionized water in a 500 mL Erlenmeyer flask. Hydrolysis was conducted in an orbital
shaker (MA 832, Marconi, Brazil) for 6 h at 70°C and 180 rpm. Gelatin in aqueous medium
was separated from chrome cake through vacuum filtration [2,5].
CTLW gelatin in aqueous medium was concentrated by water evaporation at 85°C
for as long as it was needed in order to achieve the proper concentration used for complex
coacervation.
Before being used for encapsulation process, possible traces of Cr(VI) present in the gelatin
were reduced to Cr(III) by reaction with ferrous sulfate. The reduction of Cr(VI) – a toxic
PT
oxidation state of chromium - to Cr(III) was then proved by UV-Vis Spectrophotometry
with 1-5-diphenylcarbazide, according to the method of ASTM D 1687 – 92. When
converted to Cr(III), chromium no longer produces a red-violet complex with 1-5-
diphenylcarbazide.
RI
<H3>2.2.2. Gelatin characterization
SC
Both CTLW and commercial gelatin were characterized according to their total Kjeldahl
nitrogen content (TKN), as described by SMEWW Method 4500-Norg-B. Chromium
content was determined according to SMEWW Method 3111-B through atomic absorption
U
using a spectrophotometer (Model Analyst 200, Perkin Helmer, USA) in samples
previously prepared according to SMEWW Method 3030-E.
<H3>2.2.3. Microencapsulation process N
A
The best complex coacervation condition was obtained from experiments conducted with
commercial gelatin and CEO in the concentrations shown in Table 1. The production of
M
microcapslules with gelatin from CTLW was performed only under the conditions
determined as the optimum ones for the microencapsulation with commercial gelatin.
Aqueous solutions of gelatin and sodium alginate (2%) were prepared separately by heating
D
under constant stirring at 50-55 °C for 5 minutes. Then, 200 ml of an aqueous gelatin
solution and the specific amount of were heated at 50-55°C under constant stirring for CEO
TE
The system temperature was gradually reduced to 10 °C in an ice bath during coacervation.
For the microcapsules crosslinking, glutaraldehyde solution (50% w/v) was slowly added,
until the gelatin coating appeared to be stiff.
Finally, the reticulated microcapsules were separated by centrifugation (Centrifuge Model
MA832, Marconi, Brazil) for 5 minutes at 1500 rpm and 25°C, and oven dried at 30°C
(oven model A35ED, DeLeo, Brazil). The microcapsules were stored in a desiccator.
<H3>2.2.4. Microcapsules characterization
The microcapsules were morphologically characterized by optical microscopy (OM) using
a trinocular microscope with infinity optics (TNB-40T-PL, Opton). An image capture
system coupled to a software (ISCapture, Tucsen) was employed to measure and edit the
images. Magnifications from 40 to 100X were used.
Equation 1 was used to determine average particle diameter of the microcapsules.
𝑑𝑝 ∗𝑓𝜇𝑚
PT
𝐷𝑎 = 𝑖𝑛 (1)
𝑅𝑖 ∗𝑀
RI
Where:
SC
dp: diameter [linear pixels];
U
𝑀: magnifying power [40X or 100X];
Encapsulation yield, which relates the microcapsules mass obtained to the mass of
D
non-solvents that are fed in the system, was calculated using Equation 2 [21].
TE
𝑊𝑀
𝑌𝑖𝑒𝑙𝑑 = 𝑥 100 (2)
𝑊𝑁𝑆
EP
Where:
WNS: non-solvent mass fed in the system (gelatin + sodium alginate) [g];
Encapsulation efficiency, which indicates the amount of active agent encapsulated in the
process, is defined by the Equation 3 [13]. For the determination of encapsulation
efficiency, 3 g of microcapsules were dispersed in 10 mL of hexane. This dispersion was
then stirred in an orbital shaker (MA 832, Marconi, Brazil) for 6 h at 130 rpm and 30°C to
extract the core material of the microcapsules. The solution was allowed to stand for two
hours and then filtered. The quantitative analysis of the supernatant was performed by gas
chromatography coupled to mass spectrometry (GC-MS) (6890-GC / MS-5973, HP, USA).
𝑚1
𝐸𝐸 (%) = 𝑥100 (3)
𝑚2
Where:
PT
EE: encapsulation efficiency [%];
RI
m2: mass of CEO fed in the process [g];
SC
Ash content was determined according to ASTM D2617-2012 in order to compare the
amount of non-volatile inorganic content in microcapsules produced with commercial
U
gelatin to the same content in microcapsules produced with CTLW gelatin.
<H1>1. RESULTS AND DISCUSSION
N
A
<H2>1.1. Commercial gelatin and CTLW gelatin characterization
M
Commercial and CTLW gelatin should present similar protein concentration in aqueous
media, so that microencapsulation with both can be compared. Table 2 presents their
D
characterization. CTLW gelatin was concentrated until reaching TKN value similar to the
one of the diluted commercial gelatin.
TE
Even though hydrolysis was performed in this study under the same conditions used by
Scopel et al. [2], the authors obtained gelatin with 2200 mg NH3-N/L, and with chromium
content lower than 0.04 mg/L. CTLW used by Scopel et al. [2] and the one used in this
EP
study were obtained from different tanneries. This probably explains the different protein
and chromium concentrations in both gelatin samples produced by hydrolysis. Despite
these differences, hydrolysis process was still able to increase protein:chromium proportion
CC
in gelatin when compared to CTLW: from 13:1 to 1296:1. It proves that the process was
able to extract gelatin with low amounts of chromium solubilized in it.
Commercial and CTLW gelatin extraction processes are also different. Gelatin extraction
from CTLW involves a more aggressive process, since collagen is bonded to chromium,
A
and this chemical bond has to be broken so that collagen can be extracted as gelatin. More
aggressive processes tend to result in partial hydrolysis of gelatin, reducing its molar mass.
In addition, commercial gelatin undergoes a purification step after its extraction, removing
inorganic substances, which was not performed in the gelatin here produced, resulting in
higher ash content for CTLW gelatin, as it is seen in Table 2. Therefore, CTLW gelatin
quality is different from commercial gelatin’s quality.
<H2>1.2. Determination of gelatin and CEO concentration for better quality
microcapsules production
Figures 1 to 3 show the commercial gelatin microcapsules produced by complex
coacervation. When low gelatin concentrations were used (4ComG/4CEO and
4ComG/10CEO samples), microcapsules with similar morphologies were produced. In
these samples, the only change was the CEO concentration: from 4% v/v to 10% v/v. At
100X magnification, it is possible to observe the active agent (CEO) without the cover of
the encapsulating agent.
PT
When concentration of gelatin is increased to 10% w/v (10ComG/4CEO and
10ComG/10CEO samples) it is seen the formation of a gelatinous layer among the
spherical particles, which is seen in details at 100X magnification. According to Schmitt et
al. [23], high concentrations of encapsulating agents in solution can lead to an excess of
RI
charges, negatively influencing the formation of the complexes. Another important factor
observed by Saravanan, Rao [24] is the increase in viscosity caused by higher
SC
concentrations of gelatin. It changes the stirring pattern, since the mobility of the magnetic
stirring bar oscillates according to the viscosity of the medium and affects the
homogeneous formation of microparticles.
When 7% w/v of active agent and gelatin is used (sample 7ComG/7CEO), it is not
U
observed such a prominent formation of the gelatinous layer surrounding the
microcapsules.
N
A
The images indicate that the sample 4ComG/10CEO presented better morphological results
M
in microencapsulation.
D
Particle diameter results confirmed the differences found in the micrographs for
microcapsule sizes. Average diameter for each sample, as well as their encapsulation yield,
TE
is presented in Table 3. As determined by Oxley (2014) [7], due to their diameter, the
samples can be classified as microcapsules.
EP
Even though the sample 10ComG/4CEO presented the highest encapsulation yield, its
morphology was not as good as expected. CEO and gelatin were dispersed around the
CC
microcapsules.
Taking into account morphology, the microcapsules produced with the concentration of 4%
A
core completely covered by the CTLW gelatin and sodium alginate. Their average diameter
was of 434.06 µm ± 104.68 and the encapsulation efficiency was equal to 73.7%. Xing et
al. [25] considered efficiencies from 70 % to 84 % relatively high, and so can be considered
PT
the efficiency found for the process here described.
Table 4 shows the characterization of microcapsules produced with commercial gelatin and
RI
gelatin extracted from CTLW. The analysis confirmed what had already been observed by
other authors: CTLW gelatin presents higher ash content than commercial gelatin [2,26].
SC
Figure 5 shows the results of thermogravimetry (TG / DTG) of the microcapsules
produced using CTLW gelatin. A moisture loss stage (at around 100°C) and two other main
U
mass loss stages were observed. From 230°C to 270°C it is observed the thermal event
N
related to the volatilization of the essential oil of citronella present in the sample. Asbahani
A
et al. [27] indicate that citronella essential oil typically decomposes at 201-207°C. This
M
temperature is increased when the oil is encapsulated since degradation of shell material
(gelatin and sodium alginate) needs to start so that the oil may be released. Bezerra et al.
D
[28] have also pointed to citronella oil release at the temperature interval of 233°C to 272°C
TE
from microcapsules produced with gelatin and gum Arabic. A mass loss of about 14% is
EP
The decomposition of the gelatin-sodium alginate complex is seen from 280°C to 420°C.
As stated by both Bezerra et al. [28] and Devi, Kakati [29], gelatin’s degradation event has
its peak temperature at ≈ 300°C. Sodium alginate degrades at ≈ 245°C, gelatin-sodium
A
alginate complex, however, presents a thermogravimetric behavior more similar to the one
of gelatin, degrading from about 270°C to 430°C [29].
Toxicity of microcapsules produced with CTLW gelatin should not be a matter of concern
due to reduced chromium concentration. Possible direct contact with the skin should not
cause toxic effects, since leather itself has a certain amount of soluble chromium, which is
released to human skin when leather goods are used [30]. Disposition of these
microcapsules are not a problem as well, since CTLW hydrolysate – a product similar to
CTLW gelatin, but with smaller molecular chain size and higher concentration of
chromium – is widely used as fertilizer and is in accordance to The European Commission,
Fertilizer Working Group Meeting [31].
<H1>2. CONCLUSION
The main objective of this study was to determine whether it was possible to produce
microcapsules using CTLW gelatin, which is known to present properties different from the
ones presented by commercial gelatin. Further studies are needed in order to determine
CTLW gelatin microcapsules physical and thermal stability, shelf life, biological and
PT
functional activities.
Complex coacervation of CEO with commercial gelatin and sodium alginate produced
better morphological qualities in microcapsules when lower gelatin concentrations (4%)
RI
and higher CEO concentrations (10%) were used. These concentrations, when employed to
the same process, but with CTLW gelatin instead of the commercial one, allowed a high
encapsulation efficiency (73.7%) and the production of microcapsules with 434.06 µm of
SC
diameter. Microcapsules produced with CTLW gelatin presents higher ash content due to
the absence of any purification step of the CTLW gelatin. CTLW gelatin also changed the
morphology of the microcapsules, which still were successfully produced.
U
Even though toxicity of microcapsules produced from CTLW gelatin should not be an
issue, until it is properly tested, uses that do not lead to direct contact with human skin –
such as in mosquito nets placed in windows – are suggested.
AKNOWLEGMENTS N
A
This work was supported by University of Caxias do Sul and by the Brazilian National
M
Council for Scientific and Technological Development (CNPq) for the financial support
D
<REF>References
<BIBL>
EP
[1] Ocak, B., Aslan, A., Gürbüz, G.;1;: Utilization of chroumium-tanned leather solid
wastes in microencapsulation. JALCA 106, 232-238 (2010).
[2] Scopel, B.S., Lamers, D.L., Matos, E., Baldasso, C., Dettmer,;1; A.: Collagen
CC
PT
(tea tree) oil by using simple coacervation method. J. Essent. Oil Res. 23, 58-65
(2011).
[9] Dong, Z., Ma, Y., Hayat, K., Jia, C., Xia, S., Zhang, X.;1;: Morphology and release
profile of microcapsules encapsulating peppermint oil by complex coacervation. J. Food
RI
Eng. 104(3), 455-460 (2011).
<DOI>http://dx.doi.org/10.1016/j.jfoodeng.2011.01.011</DOI>
SC
[10] Wang, B., Adhikari, B., Barrow, C.J.;1;: Optimisation of the microencapsulation of
tuna oil in gelatin–sodium hexametaphosphate using complex coacervation. Food Chem.
158(Supplement C), 358-365 (2014).
<DOI>https://doi.org/10.1016/j.foodchem.2014.02.135</DOI>
U
[11] Santos, M.G., Bozza, F.T., Thomazini, M., Favaro-Trindade, C.S.;1;:
Microencapsulation of xylitol by double emulsion followed by complex coacervation. Food
N
Chem. 171, 32-39 (2015). <DOI>http://dx.doi.org/10.1016/j.foodchem.2014.08.093</DOI>
[12] Nagpal, K., Singh, S.K., Mishra, D.N.;1;: Chitosan nanoparticles: a promising system
A
in novel drug delivery. Chemichal and Pharmaceutical Bulletin 58(11), 1423-1430
(2010).
M
[14] Li, Z., Chen, P., Xu, X., Ye, X., Wang, J.;1;: Preparation of chitosan–sodium alginate
microcapsules containing ZnS nanoparticles and its effect on the drug release. Materials
TE
and Citrus reticulata Reduce Anxiety and Prolong Ether Sleeping Time in Mice.. Tree and
forestry science and biotechnology 2, 121-124 (2008).
[16] Perini, S., Costa, G.M., Piccoli, R.H., Nunes, C.A., Bruhn, F.R.P., Custodio,;1;
CC
D.A.C.: Antimicrobial activity of essential oils against pathogens isolated from Bovine
Mastitis. Journal Of Natural Product And Plant Resources 4, 6-15 (2014).
[17] SMEWW: Macro-kjedahl method. In, vol. 4500Norg-B. (2012)
[18] SMEWW: Metals by flame atomic absorption – direct air-acetylene flame method. In,
A
PT
808-816 (2010). <DOI>http://dx.doi.org/10.1016/j.carbpol.2009.12.036</DOI>
[25] Xing, F., Cheng, G., Yang, B., Ma, L.;1;: Microencapsulation of Capsaicin by the
Complex Coacervation of Gelatin, Acacia and Tannins. J. Appl. Polym. Sci. 91,
2669–2675 (2003).
RI
[26] Mu, C., Lin, W., Zhang, M., Zhu, Q.;1;: Towards zero discharge of chromium-
containing leather waste through improved alkali hydrolysis. Waste Manage. (Oxford)
SC
23(9), 835-843 (2003). <DOI>10.1016/s0956-053x(03)00040-0</DOI>
[27] Asbahani, A.E., Miladi, K., Badri, W., Sala, M., Addi, E.H.A., Casabianca, H.,
Mousadik, A.E., Hartmann, D., Jilale, A., Renaud, F.N.R., Elaissari, A.;1;: Essential oils:
From extraction to encapsulation. Int. J. Pharm. 483(1), 220-243 (2015).
U
<DOI>https://doi.org/10.1016/j.ijpharm.2014.12.069</DOI>
[28] Bezerra, F.M., Carmona, O.G., Carmona, C.G., Lis, M.J., de Moraes, F.F.;1;:
N
Controlled release of microencapsulated citronella essential oil on cotton and
polyester matrices. Cellulose 23(2), 1459-1470 (2016). <DOI>10.1007/s10570-016-0882-
A
5</DOI>
[29] Devi, N., Kakati, D.K.;1;: Smart porous microparticles based on gelatin/sodium
M
[31] ENTR/F2/EL: Minutes of the Fertiliser Working Group Meeting. In: Chemicals, m.,
mechanical, electrical and construction industries; Raw materials; Chemicals -
Classification & Labelling, Specific Products, Competitiveness (ed.). European Comission
EP
Brussels, (2013)
CC
</BIBL>
<Figure>Figure 1 – Micrographs of CEO microcapsules produced by complex coacervation using
commercial gelatin and sodium alginate: (a) 4ComG/4CEO / 40X magnification, (b) 4ComG/4CEO / 100X
A
commercial gelatin and sodium alginate: (a) 10ComG/4CEO / 40X magnification, (b) 10ComG/4CEO /
100X magnification; (c) sample 10ComG/10CEO / 40 X magnification, and (d) sample 10ComG/10CEO /
100X magnification.
commercial gelatin and sodium alginate: (a) 7ComG/7CEO / 40X magnification, (b) 7ComG/7CEO / 100X
magnification
PT
RI
<Figure>Figure 4 - Microcapsules produced by complex coacervation using CTLW
SC
U
<Figure>Figure 5 - Thermogravimetry of microcapsules produced with CTLW (a): TG
process.
Gelatin concentration CEO concentration (%
D
Sample
(%m/v) v/v1)
TE
4ComG/4CEO 4 4
4ComG/10CEO 4 10
10ComG/4CEO 10 4
EP
10ComG/10CEO 10 10
7ComG/7CEO 7 7
1
As a function of the gelatin volume used
CC
PT
7ComG/7CEO 79.36 485.68 ± 211.82
RI
<Table>Table 4- Ash content in the microcapslules produced by complex coacervation
using commercial gelatin or CTLW gelatin and sodium alginate
SC
Ashes
Sample
(% m/m. dry basis)
U
4ComG/10CEO <1.0
4% of CTLW/10% of CEO 5.86
N
A
TDENDOFDOCTD
M
D
TE
EP
CC
A